Your browser doesn't support javascript.
loading
Dual Therapy for Refractory Overactive Bladder in Children: A Prospective Open-Label Study.
Morin, Fannie; Blais, Anne-Sophie; Nadeau, Geneviève; Moore, Katherine; Genois, Lucie; Bolduc, Stéphane.
Afiliación
  • Morin F; Division of Urology and Regenerative Medicine Axis, Research Center, University Hospital of Quebec-Laval University, Quebec, Quebec, Canada.
  • Blais AS; Division of Urology and Regenerative Medicine Axis, Research Center, University Hospital of Quebec-Laval University, Quebec, Quebec, Canada.
  • Nadeau G; Division of Urology and Regenerative Medicine Axis, Research Center, University Hospital of Quebec-Laval University, Quebec, Quebec, Canada.
  • Moore K; Division of Urology and Regenerative Medicine Axis, Research Center, University Hospital of Quebec-Laval University, Quebec, Quebec, Canada.
  • Genois L; Division of Urology and Regenerative Medicine Axis, Research Center, University Hospital of Quebec-Laval University, Quebec, Quebec, Canada.
  • Bolduc S; Division of Urology and Regenerative Medicine Axis, Research Center, University Hospital of Quebec-Laval University, Quebec, Quebec, Canada. Electronic address: stephane.bolduc@fmed.ulaval.ca.
J Urol ; 197(4): 1158-1163, 2017 04.
Article en En | MEDLINE | ID: mdl-27914999

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tiazoles / Antagonistas Muscarínicos / Vejiga Urinaria Hiperactiva / Agonistas de Receptores Adrenérgicos beta 3 / Succinato de Solifenacina / Acetanilidas Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Urol Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tiazoles / Antagonistas Muscarínicos / Vejiga Urinaria Hiperactiva / Agonistas de Receptores Adrenérgicos beta 3 / Succinato de Solifenacina / Acetanilidas Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Urol Año: 2017 Tipo del documento: Article